在再生心脏病学中通过EV交付准线粒体动力学:机制和治疗视角
Dhienda C Shahannaz1,2, Tadahisa Sugiura2, Brandon E Ferrell2
1Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
Cells
|November 13, 2025
概括
细胞外囊泡 (EVs) 通过调节线粒体动力学来显示出心脏修复的希望. 这篇评论强调了它们在再生心脏病学中的潜力,尽管临床翻译需要标准化的方法.
科学领域:
- 再生医学是一种再生医学.
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体功能障碍显著导致心脏损伤和心脏衰竭.
- 细胞外囊泡 (EVs) 被研究为用于传递线粒体载荷的治疗剂.
- 电动汽车为心脏修复中调节线粒体动态提供了一个潜在的策略.
研究的目的:
- 系统地审查关于EVs如何调节再生心脏病学中的线粒体动态的证据.
- 为了确定关键的途径和货物涉及到EV介导的线粒体调制.
- 评估基于电动汽车的心脏修复的当前挑战和未来方向.
主要方法:
- 在PubMed,Scopus和Web of Science进行全面的文献搜索,截至2025年9月.
- 包括48项专注于EV介导线粒体调制的原始研究.
- 分析了利用来自各种细胞来源的EVs的研究,包括干细胞和心脏先驱细胞.
主要成果:
- 电动汽车的货物会影响主要的线粒体动力学路径 (例如,DRP1,MFN2).
- EVs恢复线粒体膜潜力,减少活性氧物种 (ROS),并提高心肌细胞存活率.
- 工程电动汽车表现出更好的特异性,但标准化仍然是一个挑战.
结论:
- EV介导的线粒体调制是心脏修复的一个有前途的治疗策略.
- 进一步的研究需要协调协议,更深入的机械洞察力和更好的翻译准备.
- 未来的方向包括整合系统生物学和精确准,以实现先进的心脏再生.
关键词:
基于电动汽车的药物递送是基于电动汽车的.心脏再生心脏再生细胞外囊泡 (EVs) 的产生.心力衰竭治疗心力衰竭治疗线粒体生物发生和线粒体活化.线粒体的动力学线粒体转移是线粒体的转移.复原心脏病学复原心脏病学来自干细胞的EVs是干细胞衍生的.翻译性心血管医学是一种心血管医学.更多相关视频
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
6.4K
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
1.4K
相关概念视频
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
